MedTrace Logo

Effects of Vitamin D on Gut Microbiota, Intestinal Barrier in IBS-D Patients

NCT05593367 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2022-10-25

No results posted yet for this study

Summary

Irritable bowel syndrome (IBS) is a common functional gastrointestinal disease. Evidence suggests that the concentration of serum VD is decreased in IBS patients, particularly in IBS-D. After giving a supplementation of VD, some symptoms of these patients were relieved to a certain degree. However, the specific mechanism still remains unclear.

Conditions

  • Diarrhea-predominant Irritable Bowel Syndrome

Sponsors & Collaborators

  • Second Affiliated Hospital of Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • Fei Dai · Second Affiliated Hospital of Xi'an Jiaotong University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05593367 on ClinicalTrials.gov